Can Trintellix Help With Anxiety? What the Research Shows

Trintellix (vortioxetine) is a prescription antidepressant FDA approved to treat major depressive disorder (MDD). It works by influencing the activity of serotonin, a brain chemical that affects mood, emotions, and how we process stress. Because serotonin also plays a central role in anxiety, psychiatrists sometimes prescribe Trintellix off-label for anxiety disorders.

Off-label prescribing happens when a doctor prescribes a medication that’s FDA approved to treat a condition that’s different from what the patient has. This is a common occurrence, and it’s estimated that about 1 in 5 prescriptions are off-label prescriptions.

How Trintellix Can Help With Anxiety

Trintellix affects the brain's serotonin system, the same system that most anxiety medications target. What makes it somewhat different from standard antidepressants is that it influences serotonin activity in more than one way, which researchers believe may help with both the emotional and cognitive sides of anxiety, such as constant worrying, difficulty concentrating, and feeling mentally stuck.

Depression and anxiety also share a lot of the same underlying brain chemistry, which is why antidepressants often help with anxiety too, even when they were not originally designed for it. This is not unique to Trintellix. Selective serotonin reuptake inhibitors (SSRIs) like sertraline (Zoloft) and escitalopram (Lexapro) are first-line treatments for anxiety disorders, even though they were developed as antidepressants. Trintellix has been studied through the same lens.

Researchers have also studied Trintellix in people with generalized anxiety disorder (GAD), meaning persistent, hard-to-control worry that is not caused by depression. The results here are more mixed, but there is still meaningful positive data.

A meta-analysis that pooled results from seven clinical trials found that Trintellix was associated with greater reductions in anxiety symptoms than placebo after eight weeks of treatment. The researchers concluded that the evidence supported its use for anxiety disorder, while also noting that more long-term studies would strengthen confidence in that conclusion.

Take Our Quick & Easy Anxiety Questionnaire

Take Our Quick & Easy Anxiety Questionnaire

Persistent and uncontrollable anxiety that disrupts your daily life could be a sign of generalized anxiety disorder (GAD). Take this assessment to identify symptoms commonly associated with anxiety and understand if you may be suffering from an anxiety disorder.
Over the last two (2) weeks, how often have you been bothered by the following problems?

"*" indicates required fields

Step 1 of 8

Feeling nervous, anxious, or on edge
Not At AllSeveral DaysMore than Half the DaysNearly Everyday

Trintellix for Co-Occurring Anxiety and Depression

This is where the evidence for Trintellix is strongest. Depression and anxiety often occur together and many people seeking treatment are dealing with both at the same time.

A large analysis published in the Journal of Affective Disorders pooled results from 10 separate clinical trials involving adults with MDD who also had high levels of anxiety. The researchers found that Trintellix reduced anxiety symptoms meaningfully compared to placebo across all doses studied. It also did not make anxiety worse, which is an important concern with some antidepressants when first starting treatment.

The takeaway: if you are being treated for depression and also struggling with anxiety, Trintellix may help address both.

Can Trintellix Make Anxiety Worse?

Despite the research supporting its use for anxiety, Trintellix is not without caveats. Like most antidepressants, it can temporarily increase anxiety symptoms in some people during the first few weeks of treatment. This is a recognized phenomenon known as activation syndrome, which can involve increased restlessness, agitation, or a feeling of being on edge. Research published in Neuropsychiatric Disease and Treatment found that about half of patients who experience this reaction develop it within the first three days of starting an antidepressant, and most cases resolve within the first one to two weeks as the body adjusts. This is also one of the reasons psychiatrists typically start individuals on a lower dose before gradually increasing it.

Clinical trials of Trintellix found that it did not worsen anxiety over time in individuals who already had high anxiety levels at the start of treatment. But the early adjustment period is real and responses vary. Anyone who notices their anxiety increasing after starting Trintellix should contact their provider rather than stopping the medication on their own.

Is Trintellix Right for Your Anxiety?

What the research makes clear is that Trintellix is not a first-line anxiety treatment for most people, but it may be considered in specific situations, particularly when:

  • Anxiety and depression are both present at the same time
  • Anxiety symptoms are moderate to severe
  • Standard anxiety medications have not worked well enough or caused difficult side effects
  • Anxiety is noticeably affecting work, school, or daily functioning

At LifeStance, our psychiatrists take the time to understand the full picture before recommending a treatment path. Whether your symptoms call for medication, therapy, or a combination of both, LifeStance offers comprehensive evaluations, therapy, and medication management all in one place, built around what works best for you.

Connect with a LifeStance psychiatrist to discuss your anxiety symptoms and explore your options.

Trintellix is FDA approved for the treatment of major depressive disorder (MDD), not anxiety disorders. Any off-label use should be determined by a qualified healthcare provider.

References

  1. Agency for Healthcare Research and Quality. (2015, September). Off-label drugs: What you need to know. https://www.ahrq.gov/patients-consumers/patient-involvement/off-label-drug-usage.html

  2. Baldwin, D. S., Florea, I., Jacobsen, P. L., Zhong, W., & Nomikos, G. G. (2016). A meta-analysis of the efficacy of vortioxetine in patients with major depressive disorder (MDD) and high levels of anxiety symptoms. Journal of Affective Disorders, 206, 140–150. https://doi.org/10.1016/j.jad.2016.07.015

  3. Harada, T., Inada, K., Yamada, K., Sakamoto, K., & Ishigooka, J. (2014). A prospective naturalistic study of antidepressant-induced jitteriness/anxiety syndrome. Neuropsychiatric Disease and Treatment, 10, 2115–2121. https://doi.org/10.2147/NDT.S70637

  4. Sinclair, L. I., Christmas, D. M., Hood, S. D., Potokar, J. P., Robertson, A., Isaac, A., Srivastava, S., Nutt, D. J., & Davies, S. J. C. (2009). Antidepressant-induced jitteriness/anxiety syndrome: Systematic review. The British Journal of Psychiatry, 194(6), 483–490. https://doi.org/10.1192/bjp.bp.107.048371

  5. Yee, A., Ng, C. G., & Seng, L. H. (2018). Vortioxetine treatment for anxiety disorder: A meta-analysis study. Current Drug Targets, 19(12), 1412–1423. https://pubmed.ncbi.nlm.nih.gov/29149828/

Get Expert Mental Health Insights & Tips

Authored By 

Joshua Nathan, MD

Dr. Joshua Nathan, a Board-Certified Psychiatrist, and a Distinguished Fellow of the American Psychiatric Association, sees stigma – from others and from ourselves - as the biggest challenge in mental illness treatment. He encourages people to not judge themselves on...